General Information of the Compound
Compound ID
CP0091992
Compound Name
4-benzyl-2,6-diisobutylamino-pyrimidine
    Show/Hide
Synonyms
4-benzyl-2,6-diisobutylamino-pyrimidine
CHEMBL493703
    Show/Hide
Structure
Formula
C19H29N5
Molecular Weight
327.476
Canonical SMILES
CC(C)CNc1cc(NCc2ccccc2)nc(NCC(C)C)n1
    Show/Hide
InChI
InChI=1S/C19H29N5/c1-14(2)11-20-17-10-18(21-13-16-8-6-5-7-9-16)24-19(23-17)22-12-15(3)4/h5-10,14-15H,11-13H2,1-4H3,(H3,20,21,22,23,24)
    Show/Hide
InChIKey
ZOQDUFOUNDLFCC-UHFFFAOYSA-N
Physicochemical Property
logP
4.2245
Rotatable Bonds
9
Heavy Atom Count
24
Polar Areas
61.87
Hydrogen Bond Donor Count
3
Hydrogen Bond Acceptor Count
5
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 25130896
SID: 56455269
ChEMBL ID
CHEMBL493703
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00886, Estrogen receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000209 HEC-1 Homo sapiens (Human)  1
1
IC50 = 9500 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki > 7300 nM
Clinical Information about the Compound
Drug 1 ( 4-benzyl-2,6-diisobutylamino-pyrimidine )
Drug Name 4-benzyl-2,6-diisobutylamino-pyrimidine
Target(s)
Estrogen receptor (ESR)
Inhibitor